Effects of polymorphisms in ABCG2, SLCO1B1, SLC10A1 and CYP2C9/19 on plasma concentrations of rosuvastatin and lipid response in Chinese patients

Effects of the lipid environment, cholesterol and bile acids on the function of the purified and reconstituted human ABCG2 protein

(2012) Ágnes Telbisz et al.   BIOCHEMICAL JOURNAL

Genetic Determinants of Statin-Induced Low-Density Lipoprotein Cholesterol Reduction

(2012) Daniel I. Chasman et al.   Circulation-Cardiovascular Genetics

A simple assay for the simultaneous determination of rosuvastatin acid, rosuvastatin-5S-lactone, and N-desmethyl rosuvastatin in human plasma using liquid chromatography–tandem mass spectrometry (LC-MS/MS)

(2011) Joyce S. Macwan et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Interaction of angiotensin receptor type 1 blockers with ATP-binding cassette transporters

(2010) J. Weiss et al.   BIOPHARMACEUTICS & DRUG DISPOSITION

ABCG2 Polymorphism Is Associated With the Low-Density Lipoprotein Cholesterol Response to Rosuvastatin

(2010) B Tomlinson et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The ABCG2 transporter and its relations with the pharmacokinetics, drug interaction and lipid-lowering effects of statins

(2010) Miao Hu et al.   Expert Opinion on Drug Metabolism & Toxicology

Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients

(2010) Miao Hu et al.   Pharmacogenetics and Genomics

Differential effect of genetic variants of Na+-taurocholate co-transporting polypeptide (NTCP) and organic anion-transporting polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitors

(2010) Min-Koo Choi et al.   XENOBIOTICA

Impact of OATP transporters on pharmacokinetics

(2009) A Kalliokoski et al.   BRITISH JOURNAL OF PHARMACOLOGY

ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin

(2009) J E Keskitalo et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs

(2009) Alice Cristina Rodrigues et al.   PHARMACOGENOMICS

The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy

(2009) S P R Romaine et al.   PHARMACOGENOMICS JOURNAL

Population pharmacokinetics of rosuvastatin: implications of renal impairment, race, and dyslipidaemia

(2008) Tsang-Bin Tzeng et al.   CURRENT MEDICAL RESEARCH AND OPINION

Physiologically Based Pharmacokinetic Modeling to Predict Transporter-Mediated Clearance and Distribution of Pravastatin in Humans

(2008) T. Watanabe et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS